Skip to search formSkip to main contentSkip to account menu

rilonacept

Known as: interleukin-1 (IL-1) trap, IL-1 Trap, rilonacept [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Arcalyst

Broader (1)

Recombinant Fusion Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract 12851: Efficacy and Safety of Rilonacept in Recurrent Pericarditis: A Multicenter Phase 2 Clinical Trial
Introduction: Interleukin-1 (IL-1) mediates innate autoinflammation and is implicated in recurrent pericarditis (RP). We report… 
2019
2019
RILONACEPT IN RECURRENT PERICARDITIS: FIRST EFFICACY AND SAFETY DATA FROM AN ONGOING PHASE 2 PILOT CLINICAL TRIAL
Review
2018
Review
2018
Interventions for reducing inflammation in familial Mediterranean fever.
BACKGROUND Familial Mediterranean fever, a hereditary auto-inflammatory disease, mainly affects ethnic groups living in the… 
2014
2014
Diagnosis and treatment of gout
Gout is an ancient disease that has caused pain and suffering over many centuries. The tragedy is that today we have excellent… 
2013
2013
FRI0368 GOUT flare prevention with rilonacept in patients with TOPHI and/or polyarticular disease who initiate uric acid-lowering therapy
Background Patients (pts) with visible tophi and/or polyarticular disease (T/PD) may be at greater risk of gout flares (GFs) when… 
Review
2013
Review
2013
THU0401 Successful use of canakinumab in adult-onset still’s disease refractory to short acting IL-1 inhibitors
Background Adult onset Still’s Disease (AOSD) is a protean systemic seronegative spondyloarthropathy with, often dramatic… 
2012
2012
The need to compare rilonacept against active treatment for prevention of gout flares: comment on the article by Schumacher et al.
2009
2009
Empfehlungen zur Therapie mit Interleukin-1β-blockierenden Wirkstoffen
ZusammenfassungAls Interleukin- (IL-)1β blockierender Wirkstoff steht in Deutschland bislang Anakinra (ANR) zur Verfügung (Stand… 
Review
2009
Review
2009
Progress in the research of the interleukin-1 blocker rilonacept
Cryopyrin-associated periodic syndromes(CAPS) is a spectrum of rare inherited inflammatory diseases,including familial cold… 
2008
2008
New drugs: methylnaltrexone bromide, alvimopan, and rilonacept.
Agent for opioid-induced constipation Each year, an estimated 1.5 million Americans are treated with an opioid analgesic (e.g… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)